Rapid and Electronic Identification and Quantification of Age‐Specific Circulating Exosomes via Biologically Activated Graphene Transistors
Reza Hajian, Jonalyn DeCastro, Jonathan Parkinson, Alex Kane, Andres Felipe Romero Camelo, Peichi Peggy Chou, Jielin Yang, Nathan Wong, Ecson Daniel Obando Hernandez, Brett Goldsmith, Irina M. Conboy, Kiana Aran
Abstract
Abstract Increasing access to modern clinical practices concomitantly extends lifespan, ironically revealing new classes of degenerative and inflammatory diseases of later years. Here, an electronic graphene field‐effect transistor (gFET) is reported, termed EV‐chip, for label‐free, rapid identification and quantification of exosomes (EV) associated with aging through specific surface markers, CD63 and CD151. Studies suggest that blood‐derived exosomes carry specific biomolecules that can be used toward diagnostic applications of age and health. However, to observe improvements in patient outcomes, earlier detection at the point‐of‐care (POC) is required. Unfortunately, conventional techniques and other electronic‐based platforms for exosome sensing are burdensome and inept for the POC distinction of aged blood factors. It is shown that EV‐chip can quantitatively detect purified exosomes from plasma, with a limit of detection (LOD) of 2 × 10 4 particles mL −1 and a limit of quantification (LOQ) of 6 × 10 4 particles mL −1 . The sensitivity and compact electronics of the EV‐chip improves upon previously published electronic biosensors, making it ideal for a physician's office or a simple biological laboratory. The sensitivity, selectivity, and portability of the EV‐chip demonstrate the potential of the biosensor as a powerful point‐of‐care diagnostic and prognostic tool for age‐related diseases.